US Stock MarketDetailed Quotes

Heron Therapeutics (HRTX)

Watchlist
  • 1.440
  • -0.010-0.69%
Trading Jan 23 11:56 ET
264.04MMarket Cap-16.00P/E (TTM)

Heron Therapeutics (HRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
16.47%38.21M
3.26%37.2M
12.21%38.9M
13.57%144.29M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
17.99%127.04M
14.00%34.23M
Operating revenue
16.47%38.21M
3.26%37.2M
12.21%38.9M
13.57%144.29M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
17.99%127.04M
14.00%34.23M
Cost of revenue
25.97%11.91M
-6.28%9.86M
0.15%8.46M
-40.64%38.65M
3.47%10.23M
-48.06%9.46M
-47.82%10.52M
-49.90%8.44M
18.64%65.11M
-21.72%9.89M
Gross profit
12.62%26.3M
7.20%27.34M
16.09%30.45M
70.55%105.64M
25.48%30.55M
76.56%23.35M
119.80%25.51M
105.52%26.23M
17.31%61.94M
39.92%24.35M
Operating expense
9.28%30.39M
-9.30%28.98M
-12.03%27.29M
-32.10%117.17M
-23.69%26.38M
-27.11%27.81M
-40.84%31.95M
-32.30%31.02M
-24.14%172.55M
-8.44%34.57M
Selling and administrative expenses
15.32%26.92M
-5.35%26.05M
-5.31%25.01M
-24.69%100.48M
-13.32%23.2M
-19.14%23.35M
-32.55%27.52M
-28.58%26.42M
-7.83%133.42M
-48.03%26.77M
-Selling and marketing expense
17.95%12.94M
-14.98%11.58M
7.59%12.31M
-30.39%47.09M
-10.31%11.06M
-15.31%10.97M
-35.80%13.61M
-45.91%11.44M
-18.02%67.64M
-30.64%12.33M
-General and administrative expense
12.99%13.98M
4.07%14.47M
-15.17%12.7M
-18.82%53.4M
-15.88%12.15M
-22.25%12.37M
-29.03%13.91M
-5.43%14.97M
5.69%65.78M
-57.19%14.44M
Research and development costs
-22.28%3.47M
-33.80%2.93M
-50.54%2.28M
-57.37%16.68M
-59.27%3.18M
-51.91%4.47M
-66.45%4.43M
-47.85%4.61M
-52.68%39.13M
156.76%7.8M
Operating profit
8.19%-4.09M
74.60%-1.64M
165.74%3.15M
89.58%-11.53M
140.83%4.17M
82.12%-4.46M
84.80%-6.45M
85.49%-4.8M
36.67%-110.62M
49.79%-10.22M
Net non-operating interest income expense
-392.46%-2.48M
39.71%-504K
Non-operating interest income
----
----
----
5.53%3.55M
----
----
----
----
105.37%3.36M
----
Non-operating interest expense
----
----
----
55.95%6.03M
----
----
----
----
56.35%3.87M
----
Other net income (expense)
-3,336.41%-13.4M
73.33%-744K
-131.68%-519K
-23.21%430K
1.97M
-393.67%-390K
-911.05%-2.79M
455.25%1.64M
108.58%560K
0
Special income (charges)
---11.34M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--11.34M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-428.97%-2.06M
73.33%-744K
-131.68%-519K
-23.21%430K
--1.97M
-393.67%-390K
-911.05%-2.79M
455.25%1.64M
108.58%560K
--0
Income before tax
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
Income tax
Net income
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
Net income continuous Operations
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
Minority interest income
Net income attributable to the parent company
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
Basic earnings per share
-233.33%-0.1
66.67%-0.02
200.00%0.02
88.75%-0.09
140.00%0.02
82.35%-0.03
82.86%-0.06
92.59%-0.02
52.10%-0.8
70.59%-0.05
Diluted earnings per share
-233.33%-0.1
66.67%-0.02
200.00%0.02
88.75%-0.09
140.00%0.02
82.35%-0.03
82.86%-0.06
92.59%-0.02
52.10%-0.8
70.59%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 16.47%38.21M3.26%37.2M12.21%38.9M13.57%144.29M19.13%40.78M4.38%32.81M13.42%36.02M17.07%34.67M17.99%127.04M14.00%34.23M
Operating revenue 16.47%38.21M3.26%37.2M12.21%38.9M13.57%144.29M19.13%40.78M4.38%32.81M13.42%36.02M17.07%34.67M17.99%127.04M14.00%34.23M
Cost of revenue 25.97%11.91M-6.28%9.86M0.15%8.46M-40.64%38.65M3.47%10.23M-48.06%9.46M-47.82%10.52M-49.90%8.44M18.64%65.11M-21.72%9.89M
Gross profit 12.62%26.3M7.20%27.34M16.09%30.45M70.55%105.64M25.48%30.55M76.56%23.35M119.80%25.51M105.52%26.23M17.31%61.94M39.92%24.35M
Operating expense 9.28%30.39M-9.30%28.98M-12.03%27.29M-32.10%117.17M-23.69%26.38M-27.11%27.81M-40.84%31.95M-32.30%31.02M-24.14%172.55M-8.44%34.57M
Selling and administrative expenses 15.32%26.92M-5.35%26.05M-5.31%25.01M-24.69%100.48M-13.32%23.2M-19.14%23.35M-32.55%27.52M-28.58%26.42M-7.83%133.42M-48.03%26.77M
-Selling and marketing expense 17.95%12.94M-14.98%11.58M7.59%12.31M-30.39%47.09M-10.31%11.06M-15.31%10.97M-35.80%13.61M-45.91%11.44M-18.02%67.64M-30.64%12.33M
-General and administrative expense 12.99%13.98M4.07%14.47M-15.17%12.7M-18.82%53.4M-15.88%12.15M-22.25%12.37M-29.03%13.91M-5.43%14.97M5.69%65.78M-57.19%14.44M
Research and development costs -22.28%3.47M-33.80%2.93M-50.54%2.28M-57.37%16.68M-59.27%3.18M-51.91%4.47M-66.45%4.43M-47.85%4.61M-52.68%39.13M156.76%7.8M
Operating profit 8.19%-4.09M74.60%-1.64M165.74%3.15M89.58%-11.53M140.83%4.17M82.12%-4.46M84.80%-6.45M85.49%-4.8M36.67%-110.62M49.79%-10.22M
Net non-operating interest income expense -392.46%-2.48M39.71%-504K
Non-operating interest income ------------5.53%3.55M----------------105.37%3.36M----
Non-operating interest expense ------------55.95%6.03M----------------56.35%3.87M----
Other net income (expense) -3,336.41%-13.4M73.33%-744K-131.68%-519K-23.21%430K1.97M-393.67%-390K-911.05%-2.79M455.25%1.64M108.58%560K0
Special income (charges) ---11.34M------------------0----------------
-Less:Other special charges --11.34M------------------------------------
Other non- operating income (expenses) -428.97%-2.06M73.33%-744K-131.68%-519K-23.21%430K--1.97M-393.67%-390K-911.05%-2.79M455.25%1.64M108.58%560K--0
Income before tax -260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M
Income tax
Net income -260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M
Net income continuous Operations -260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M
Minority interest income
Net income attributable to the parent company -260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M
Basic earnings per share -233.33%-0.166.67%-0.02200.00%0.0288.75%-0.09140.00%0.0282.35%-0.0382.86%-0.0692.59%-0.0252.10%-0.870.59%-0.05
Diluted earnings per share -233.33%-0.166.67%-0.02200.00%0.0288.75%-0.09140.00%0.0282.35%-0.0382.86%-0.0692.59%-0.0252.10%-0.870.59%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More